Work

Sierra Clinical Trial Dosimetry Results Support Low Dose Anti-CD45 Iodine (131I) Apamistamab [Iomab-B] for Targeted Lymphodepletion Prior to Adoptive Cell Therapy

Year: 2019

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2019-128838

Authors: Rajneesh Nath, Eileen M Geoghegan, Matthew L. Ulrickson, Jennifer A Spross, Renee H Lichtenstein, Sandy Konerth, Darrell R. Fisher, Qing Liang, Dale Ludwig, Vijay Reddy, Mark S. Berger, Boglarka Gyurkocza

Institutions: Banner MD Anderson Cancer Center, Actinium Pharmaceuticals (United States), Memorial Sloan Kettering Cancer Center

Language: English

Topic: Radiopharmaceutical Chemistry and Applications

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2988534895

Cites:

Cited by: 3

Related to: 10